Genprex (GNPX) Net Income towards Common Stockholders (2016 - 2025)

Genprex (GNPX) has 9 years of Net Income towards Common Stockholders data on record, last reported at -$3.8 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 11.97% year-over-year to -$3.8 million; the TTM value through Sep 2025 reached -$16.8 million, up 27.05%, while the annual FY2024 figure was -$21.4 million, 30.69% up from the prior year.
  • Net Income towards Common Stockholders reached -$3.8 million in Q3 2025 per GNPX's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$3.4 million in Q3 2021 and bottomed at -$9.2 million in Q1 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 78.67% in 2022, then skyrocketed 44.2% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$6.8 million in 2021, then rose by 3.36% to -$6.5 million in 2022, then grew by 9.12% to -$5.9 million in 2023, then increased by 26.95% to -$4.3 million in 2024, then rose by 12.27% to -$3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$3.8 million in Q3 2025, -$4.7 million in Q2 2025, and -$4.0 million in Q1 2025.